» Authors » Luis C Farhat

Luis C Farhat

Explore the profile of Luis C Farhat including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 221
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ostinelli E, Schulze M, Zangani C, Farhat L, Tomlinson A, Del Giovane C, et al.
Lancet Psychiatry . 2024 Dec; 12(1):32-43. PMID: 39701638
Background: The comparative benefits and harms of available interventions for ADHD in adults remain unclear. We aimed to address these important knowledge gaps. Methods: In this systematic review and component...
2.
Koenig J, Farhat L, Bloch M
J Child Psychol Psychiatry . 2024 Dec; 66(1):1-3. PMID: 39690123
The transition from adolescence into adulthood is a pivotal phase in a person's life, marking a period of significant social, psychological, and biological changes that can profoundly impact an individual's...
3.
Duarte I, Hoffmann M, Salum G, Leffa D, Belangero S, Santoro M, et al.
Eur Child Adolesc Psychiatry . 2024 Dec; PMID: 39625683
Translation of biomarkers to clinical practice is hindered by the significant overlap in neurobiological measures between ADHD cases and controls. A risk-informed design can enhance the utility and validation of...
4.
Macul Ferreira de Barros P, Farhat L, Behling E, Nasir M, Landeros-Weisenberger A, Bloch M
J Am Acad Child Adolesc Psychiatry . 2024 Nov; PMID: 39505141
Objective: To examine the magnitude of placebo response in randomized controlled trials (RCTs) of medications for Tourette's disorder. Method: CENTRAL, Embase, PubMed, PsycInfo, Web of Science, WHO ICTRP, and ClinicalTrials.gov...
5.
Farhat L, Behling E, Landeros-Weisenberger A, Macul Ferreira de Barros P, Polanczyk G, Cortese S, et al.
J Child Adolesc Psychopharmacol . 2024 Sep; 34(9):373-382. PMID: 39320340
To evaluate the comparative efficacy of pharmacological interventions for children and adolescents with a dual diagnosis of persistent tic disorders or Tourette disorder and attention-deficit/hyperactivity disorder (TD + ADHD). We...
6.
Olfson E, Farhat L, Liu W, Vitulano L, Zai G, Lima M, et al.
Nat Commun . 2024 Jul; 15(1):5870. PMID: 38997333
Research demonstrates the important role of genetic factors in attention-deficit/hyperactivity disorder (ADHD). DNA sequencing of families provides a powerful approach for identifying de novo (spontaneous) variants, leading to the discovery...
7.
Reid M, Lin A, Farhat L, Fernandez T, Olfson E
Compr Psychiatry . 2024 Jun; 133:152506. PMID: 38833896
Background: Trichotillomania (TTM) and excoriation disorder (ED) are impairing obsessive-compulsive related disorders that are common in the general population and for which there are no clear first-line medications, highlighting the...
8.
Ramakrishnan D, Farhat L, Vattimo E, Levine J, Johnson J, Artukoglu B, et al.
J Psychiatr Res . 2024 Apr; 173:387-397. PMID: 38598877
Introduction: Expert consensus operationalized treatment response and remission in obsessive-compulsive disorder (OCD) as a Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) reduction ≥35% and score ≤12 with ≤2 on Clinical Global Impressions Improvement...
9.
Farhat L, Flores J, Avila-Quintero V, Polanczyk G, Cipriani A, Furukawa T, et al.
JAMA Psychiatry . 2023 Oct; 81(2):157-166. PMID: 37878348
Importance: Stimulants (methylphenidate and amphetamines) are often prescribed at unlicensed doses for adults with attention-deficit/hyperactivity disorder (ADHD). Whether dose escalation beyond US Food and Drug Administration recommendations is associated with...
10.
Sugaya L, Farhat L, Califano P, Polanczyk G
JCPP Adv . 2023 Sep; 3(3):e12146. PMID: 37720577
Background: Robust synthesis of evidence to support treatment recommendations for preschoolers with attention-deficit/hyperactivity disorder (ADHD) is lacking. The aim of this systematic review and meta-analysis was to review currently available...